All posts by imreal

Business: Executives

Lido Advisors Finishes Record Banner Year of High Rankings, Top Awards and Executive Honors

Leave a comment


Lido Advisors, LLC

“We are doubly honored that the Los Angeles Business Journal has recognized Lido Advisors for our firm as a whole and for three of our talented colleagues who help make us one of the fastest-growing financial advisory firms practicing today,” said Ken Stern, Senior Managing Director, Lido Advisors.


LOS ANGELES (PRWEB)

Lido Advisors, LLC, a Los Angeles-based, full-service, independent, Registered Investment Advisory firm (“RIA”), officially closed out banner year 2019 with a wide assortment of notable and exclusive awards, honors, rankings and achievements.

In assets under management alone, Lido grew from $3.5B in January 2019 to right around $5.3B in AUM by year’s end, a feat that landed the firm on more than one prestigious list in the press.1

The year began with the major merger of Ken Stern & Associates, adding new depth to Lido’s client service offerings and knowledge. Ken Stern & Associates managed over $400M in assets.

In the summer, Coliseum Wealth joined Lido Advisors in the firm’s first bicoastal move to the east. Lido was also ranked 73rd largest RIA firm in the United States by Financial Advisor (FA) magazine.

In October, Lido acquired near-$700M wealth management group Marton Bute, extending Lido’s national presence to the southeast region and expanding its unique strategies and client services.

In November, Lido was placed at number 22 at an L.A. Biz annual event that ranked the “Top 100 Fastest Growing Private Companies” in Los Angeles County. Against the competition, this made Lido the number one standalone RIA firm in L.A. and the number two RIA firm in L.A. overall.2

In addition, three executive members of Lido Advisors were named to L.A. Biz’s annual “40 in their 40s” special, which featured the best financial executives in the Los Angeles area. They included:

Senior Managing Director, President Jason Ozur

Senior Managing Director, Alyssa Weinberger

Senior Managing Director, Jeffrey Westheimer

“We are doubly honored that the Los Angeles Business Journal has recognized Lido Advisors for our firm as a whole and for three of our talented colleagues who help make us one of the fastest-growing financial advisory firms practicing today,” said Ken Stern, Senior Managing Director, Lido Advisors.

In a December cover story that profiled Lido’s origins and growth, the firm was featured again by Financial Advisor (FA) magazine, one of the financial industry’s premier trade publications.

Also in December, Forbes published “How to Invest Like the Ultra-Wealthy Using Real Estate,” by Senior Managing Director and Chairman of Lido Advisors, Gregory Kushner – the CEO’s latest contribution to the Forbes Finance Council of authority writers and industry specialists.

It was also a notable year for women at Lido, seeing Senior Managing Director Alyssa Weinberger nominated for Woman of the Year at the Women in Asset Management Awards and receiving a rare induction into the exclusive 2019 class of Women of Influence hosted by L.A. Bizwomen.

Senior Managing Director Alexandra Browne made headlines with her featured article, “Meet the Female Leaders of Finance” in a piece with Jason Hartman from Medium’s Authority magazine.

Senior Managing Director Ken Stern was also featured in an Authority article in November.

“All in all, it was a big year for Lido Advisors, marked by significant achievements, and at our current rate of growth, 2020 stands to be even bigger,” said Marketing Manager Paul Hyman.

1Lido Advisors, LLC recognized by sources such as Financial Advisor magazine and Los Angeles Business Journal for AUM/growth data – (https://www.fa-mag.com/news/ria-survey—ranking-2019-45701.html)

2Based on number 22 ranking by Lido Advisors, LLC above all other standalone RIA firms, and coming in behind Cambria Investments at number 21 in fast growth by private companies that are also RIA firms. (https://www.cambriainvestments.com); (Published in LABJ’s November 18, 2019 issue of the journal.)

About Lido Advisors

Lido Advisors, LLC is a nationally recognized wealth advisory firm headquartered in Los Angeles, California with many offices throughout the United States. Lido seeks to provide comprehensive investment and wealth solutions designed to grow, protect, and maximize our clients’ legacies. Our focus on elegant and effective client solutions exemplifies our commitment to excellence.

Lido strives to pursue consistent growth and expansion, with innovation and integrity, providing investment and wealth strategies for select institutions and families through far-reaching wealth and investment advice, with due consideration to tax and estate planning facets of a client’s life.

To learn more about Lido Advisors, visit http://www.lidoadvisors.com.

#            #            #

Share article on social media or email:

Health

The American College of Medical Toxicology Presents the 2020 Opioid Symposium and 2020 Annual Scientific Meeting in NYC on March 12-15

Leave a comment


News Image


PHOENIX (PRWEB)

Registration is open for two exciting medical toxicology events in March 2020 at the Grand Hyatt in New York City.

The first ACMT event is a one-day symposium on Thursday, March 12, 2020, ‘Opioid Epidemic: Controversies and Creative Solutions.’ This event will go beyond the basics and discuss big-picture approaches to the opioid epidemic. We will address novel, cutting edge, and controversial approaches, including safe-injection sites, mobile buprenorphine induction, urban greening, and others.

Featured presentations and experts for ‘Opioid Epidemic: Controversies and Creative Solutions’ include:

 

Overview of the Opioid Epidemic: New York City Perspective

Lewis Goldfrank, MD, FACMT, Herbert W. Adams Professor of Emergency Medicine at New York University-Bellevue Hospital

 

The New Neurobiology of Addiction and Implications for Innovative Treatment Solutions

Petros Levounis, MD, MA, Professor and Chair, Department of Psychiatry at Rutgers New Jersey Medical Center

 

Point Counterpoint: We Should Curb Opioid Prescribing

Andrew Kolodny, MD, Senior Scientist, Institute for Behavioral Health; Co-Director of Opioid Policy Research, Heller School for Social Policy and Management at Brandeis University

 

The symposium precedes the 2020 Annual Scientific Meeting.

Learn More and register for the 2020 Symposium.

The second ACMT event is the 18th Annual Scientific Meeting on Friday, March 13-Sunday, March 15. Since 2003, the ACMT Annual Scientific Meeting (ASM) has provided an opportunity for specialists in the field of medical toxicology to gather together, network, and learn from the cutting-edge research of their peers. The event will elevate the field’s discourse by featuring national and international authorities speaking on current practices in medical toxicology.

Featured presentations for the 2020 ACMT Annual Scientific Meeting include:

Moral Toxicology: Where is the Line? 

Arthur L. Caplan, PhD, Director, Division of Medical Ethics at NYU School of Medicine

World Trade Center Health Program: Toxicological Implications 

Michael Crane, MD, MPH, Medical Director World Trade Center Health Program Clinical Center of Excellence at Mount Sinai Professor, Department of Environmental Medicine and Public Health at Mount Sinai

UK Novichok Attack

Simon Thomas, MD, Professor of Clinical Pharmacology and Therapeutics, Newcastle University and NHS Foundation Trust, Newcastle, UK; and

Stevan Emmett, MBChB, D.Phil, Principal Medical Officer and Senior Clinical Fellow, Defense Science and Technology Laboratory, UK

Exposomics: Environmental Effects on Health, Life & Disease

Robert O. Wright, MD, MPH, Professor and Ethel H Wise Chair, Department of Environmental Medicine & Public Health, Icahn School of Medicine at Mt. Sinai

Doing Harm: Examining the Drugs Used in Sexual Assault

Ann Arens, MD, Medical Toxicologist, Emergency Medicine Physician; Hennepin Healthcare, Minnesota Poison Control System

Learn more and register for the 2020 Annual Scientific Meeting.

*Early Bird discounts for both events expire on January 31, 2020.

The American College of Medical Toxicology (ACMT) is a professional, nonprofit association of physicians with recognized expertise and board certification in medical toxicology. Our members specialize in the prevention, evaluation, treatment, and monitoring of injury and illness from exposures to drugs and chemicals, as well as biological and radiological agents. ACMT members work in clinical, academic, governmental, and public health settings, and provide poison control center leadership.

Share article on social media or email:

Legal / Law: Criminal Law

Attorney John Q. Kelly and Ivey, Barnum & O’Mara, LLC Launch Podcast About the Unsolved Murder of Matthew Margolies

Leave a comment


“He was the Huckleberry Finn of The Valley


GREENWICH, Conn. (PRWEB)

With vast experience in handling high-profile cases, against O.J. Simpson, Joran van der Sloot, and Drew Peterson, Attorney John Q. Kelly introduces the public to the horrific death of Margolies, who was only 13 years old at the time of his brutal murder 35 years ago.

Attorney Kelly takes a close look at the facts and fiction surrounding this cold case that devastated the Margolies family and their working-class neighborhood. None of the members of this close-knit community, known as the “Valley,” supposedly saw or heard anything the night of the murder. Although there were initial suspects, no arrests were ever made in connection to the killing. Delays and loose ends have caused the case to remain unsolved.

In Attorney Kelly’s podcast, he discusses the case with the Margolies family, as well as other prominent figures in the criminal justice system. These include former Det. Bo Dietl of the NYPD, pathologist Michael Baden, retired LAPD Det. Mark Fuhrman and Greenwich Police Capt. Robert Berry. Dorthy Moxley, the mother of murdered Greenwich teen Martha Moxley, also weighs in.

The podcast focuses on different aspects of the case, including why Matthew’s murder did not garner much media attention, the murder weapon, and statements from potential suspects. The episodes are titled: “The Footnote Murder”; “Happy Valley”; “Absence, or Abundance, of Evidence?”; “Twin Peaks”; “Two Fishy Stories”; and “Pulling it Together.” All six episodes are now available on iTunes and other major apps.    

About John Q. Kelly, Esq.

Subsequent to his landmark verdict as lead attorney for the Estate of Nicole Brown Simpson in its wrongful death action against O.J. Simpson, John Q. Kelly continues to successfully handle a wide variety of wrongful death and personal injury matters, many of which receive national and international coverage (opposed O.J. Simpson, Joran van der Sloot, Drew Peterson, to name a few). Mr. Kelly is known to be a meticulous, no-nonsense litigator, schooled in the nuances of physical, forensic and circumstantial evidence, and battle-tested in the courtroom on countless occasions.

About Ivey, Barnum & O’Mara, LLC

Ivey, Barnum & O’Mara, LLC, is the largest Greenwich, CT-based law firm, with additional offices in New Canaan, CT and New York City. Established for more than 65 years, Ivey, Barnum & O’Mara, LLC’s team of accomplished and dedicated attorneys represent clients in a wide range of individual and corporate legal issues, including: Personal Injury/Wrongful Death, Litigation, Residential and Commercial Real Estate, Land Use/Zoning, Trusts and Estates Planning, Corporate Law, Franchise, Employment Law.

To learn more about Ivey, Barnum & O’Mara, LLC, visit https://www.ibolaw.com/ or call 203-661-6000.

Share article on social media or email:

Technology: Computer

The ChannelPro Network Announces Its Inaugural Peer of the Year Award

Leave a comment



RALEIGH, N.C. (PRWEB)

The ChannelPro Network has named Joanna Sobran, president and CEO of MXOtech in Chicago, as the inaugural winner of its Peer of the Year award.

Each month during the calendar year, ChannelPro invites a successful MSP, value-added reseller, or solution provider to share his or her story in the Peer to Peer feature that runs in the digital and print issues of ChannelPro-SMB magazine. The column provides actionable advice on topics such as growing a business, improving operations and service delivery, developing new lines of business, hiring and retention, building sales and marketing strategies, and creating and nurturing corporate culture.

All 12 stories in 2019 were considered for ChannelPro’s inaugural Peer of the Year award by the publication’s editors, who selected the one they believe readers could learn the most from and immediately apply to their own business. Sobran’s story outlines the hiring and retention process she uses, which has helped grow her IT managed services business to more than $5 million.

“Joanna’s story details a recruitment and hiring process she developed that honors the firm’s core values and embraces diversity and inclusion,” says Rich Freeman, executive editor of The ChannelPro Network. “Hiring and retention remain top challenges for IT business owners who face a tight labor market as well as a skills gap. Joanna shares sound and creative strategies that have helped her grow MXOtech, and which readers could adapt for their own businesses.”

(Read the story here https://www.channelpronetwork.com/article/hiring-take-your-business-higher)

Sobran, who came from Poland as a child with her parents, founded MXOtech, a 100% woman-owned business, in 2005. She began her career in the healthcare industry working for two successful women entrepreneurs and later moved into IT recruiting, combining her healthcare and technology business expertise. Her knowledge of these two practice areas, along with her business development and recruiting skills, became the foundation on which she built her own successful company.

“My favorite part of owning a business is matching people with their dream job, watching them make an impact, and building a great company together,” Sobran says. “Through our training program, we have changed the lives of individuals from underserved communities and foreign countries so they can do what they love while providing for their families. This is why I get up every day excited to continue our journey.”

MXOtech has been recognized as one of the nation’s fastest-growing outsourced IT companies by Inc. Magazine’s “Inc. 5000” list. MXOtech healthcare applications have also been nominated for Innovation Awards and adopted by Fortune 1000 companies. Most recently, the Women’s Business Development Center in Chicago presented Sobran with the Deborah Sawyer Rising Star Award. Visit http://www.mxotech.com

“The ChannelPro Network is honored that Joanna chose to share her story with our readers, and we are pleased to present her with our first-ever Peer of the Year award,” says Michael Siggins, president and publisher of The ChannelPro Network. “The competition was fierce, as all of our Peer to Peer stories last year were compelling sources of insight and inspiration for our readers.”

For 2020, ChannelPro will be expanding the Peer of the Year selection process to include nominees from the ChannelPro audience of readers and vendors as well as from our 12 Peer to Peer stories featured throughout the year. Interested parties can send nominations to: peer2peer@channelpronetwork.com.

About the ChannelPro Network

The ChannelPro Network provides targeted business and technology information for the IT channel. Via ChannelPro-SMB magazine, live and online events, and our online properties, the network delivers expert opinion, analysis, news, product reviews, and advice vital to a reseller’s business success. Perspectives from VARs, vendors, distributors, and analysts are spotlighted daily. No other media company focuses on the small and midsize marketplace like The ChannelPro Network. Learn more at http://www.channelpronetwork.com.

Share article on social media or email:

Technology: Electronics

Announcing Launch of ZBOSS Open Initiative (ZOI) for Royalty-Free Zigbee® PRO Stack Software

Leave a comment



DENVER (PRWEB)

DSR Corporation announces the launch of a community for Zigbee® PRO software platform, ZBOSS Open Initiative (ZOI), which aims to provide a collaboration for IoT market players with a proven, reliable, and highly interoperable Zigbee® software protocol stack, along with the required development tools and infrastructure to establish a solid ground for effective joined work on the unified Zigbee® PRO software platform.

One of the main challenges currently facing the IoT market is to achieve interoperability across the vast ecosystem of smart devices and manufacturers. The key solution to this problem is a shared software platform, utilized and maintained by chipset vendors and consumer product companies, in a collaborative environment. This joint effort will greatly reduce compatibility issues and simplify development for manufacturers, while providing the opportunity to optimize R&D costs and decrease time to market for products.

DSR Corporation will share its market-proven ZBOSS stack source-code base with ZOI members and provide all the necessary, modern tools and support to make it easier for participating companies to integrate new chips and consumer products. Joined efforts will allow for the development of a unified software platform for Zigbee®-enabled smart devices and make it the most interoperable solution on the market.

ZBOSS is a Zigbee Alliance certified, hardware agnostic, cross-platform, high-performance Zigbee® software protocol stack developed by DSR Corporation. ZBOSS features cross-platform support, multi-tasking, fixed memory footprint, OS-less configuration, and easy-to-use API. It is an official Zigbee® stack for Nordic Semiconductor and ON Semiconductor and also supports multiple SoCs, MCUs and transceivers from Texas Instruments, Silicon Labs, Qorvo, ARM, Telink, UBEC, Microchip, and other chip vendors. Moreover, multiple Zigbee® 3.0 certified products are powered by ZBOSS. Over 200 smart devices from more than 40 vendors were tested successfully for interoperability with ZBOSS.

With validation and support from several silicon vendors and product companies, DSR Corporation is excited to launch ZOI on February 7th, 2020, but interested parties can join before the official launch by contacting DSR Corporation. ZOI is just one of the steps to provide a common Zigbee® PRO software platform to address the current market needs.

If you are interested in getting involved or get additional information, please visit http://www.dsr-zoi.com.

About DSR Corporation

DSR Corporation (DSR) is a professional products and services software development firm headquartered in Denver, Colorado. DSR Corporation has been developing products in wireless technology since 2001, releasing cloud and Internet of Things (IoT) systems since 2006. DSR is the ultimate end-to-end IoT partner for many companies around the world and within different IoT verticals. DSR has delivered solutions in enabling wireless communications in products, embedded software for gateways and sensors, application integration layer, cloud backend, end-user apps (mobile and web), and general technology consulting with niche expertise. DSR is one of a handful of companies around the world that develops solutions covering the entire product spectrum – from the lowest level (hardware layer) to the top level user apps. DSR is a big supporter of open standards and flexible development, making us technology and vendor agnostic because we understand that not all solutions fit all use cases and business models. We are able to do this because of our extensive experience in different areas and our commitment to quality, recognized by our work in the Japanese market.

http://www.dsr-iot.com | http://www.dsr-zboss.com

Share article on social media or email:

Industry: Healthcare

New protocol could signal shift in bone regenerative medicine

Leave a comment



DURHAM, N.C. (PRWEB)

A new, safe and efficient way to coax stem cells into bone cells is reported in a recently published article from STEM CELLS Translational Medicine (SCTM). The protocol, developed by researchers at the University of Sydney, Australian Research Centre (ARC) for Innovative BioEngineering, could lead to a shift in the treatment of bone regenerative medicine.

Large bone defects and loss due to cancer or trauma can result in scar tissue that impairs the bones’ ability to repair and regenerate. The current gold standard therapy, autografting, has inherent drawbacks, including limited availability and donor site morbidity. This leaves researchers seeking an alternative source of bone cells — and makes bone tissue engineering a growing field with considerable translational potential.

“The success of induced pluripotent stem cell (iPSC) technology to reprogram fibroblasts into progenitor cells of various lineages offers an exciting route for tissue repair and regeneration,” said Zufu Lu, Ph.D., a member of the University of Sydney’s Biomaterials and Tissue Engineering Research Unit and a research associate at the ARC for Innovative BioEngineering. He is a co-lead investigator of the SCTM study, along with Professor Hala Zreiqat, Ph.D., head of the research unit and director of the ARC Training Centre for Innovative BioEngineering.

“However, while iPSC technology represents a potentially unlimited source of progenitor cells and allows patients to use their own cells for tissue repair and regeneration — thus posing little or no risk of immune rejection – the technology has several constraints. Among them are the requirement for complex reprogramming using the Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc). To add to the complexity, specific stimuli are required to direct iPSCs to re-differentiate to progenitor cells of the lineage of interest.

“In addition,” Dr. Lu said, “any remaining iPSCs pose the risk of tumors following implantation.”

One potential way around this, as demonstrated by recent studies, is through the direct reprogramming of fibroblasts into bone cells. “Fibroblasts are morphologically similar to osteoblasts. Their similar transcriptomic profiles led us to hypothesize that distinct factors produced by osteoblasts may be capable of coaxing fibroblasts to become osteoblast-like cells,” Prof. Zreiqat said.

Previous studies aimed at using fibroblasts to produce various cell types relied on the genetic manipulation of one or more transcription regulators. But just as with iPSCs, reprogramming fibroblasts in this manner has its own inherent technical and safety issues. The Lu-Zreiqat team, however, surmised that an approach employing natural factors might just allow better control over reprogramming and improve the safety.

“Unlike genetic reprogramming, chemical induction of cell reprogramming is generally rapid and reversible, and is also more amenable to control through factor dosage and/or combinations with other molecules,” Dr. Lu explained.

The team initially determined that media conditioned by human osteoblasts can induce reprogramming of human fibroblasts to functional osteoblasts. “Next,” said Prof. Zreiqat, “our proteomic analysis identified a single naturally bioactive protein, insulin growth factor binding protein-7 (IGFBP7), as being significantly elevated in media conditioned with osteoblasts, compared to those with fibroblasts.”

This led them to test IGFBP7’s ability as a transcription factor. They found it, indeed, successfully induced a switch from fibroblasts to osteoblasts in vitro. They next tested it in a mouse model — and once again experienced success when the fibroblasts produced mineralized tissue. The switch was associated with senescence and dependent on autocrine IL-6 signaling.

“The approach we describe in our study has significant advantages over other commonly used cell sources including iPSCs and adult mesenchymal stem cells,” Dr. Lu and Prof Zreiqat concluded.

“Bone tissue engineering is a growing field where cell therapies have considerable translational potential, but current cell-based approaches face limitations,” said Anthony Atala, M.D., Editor-in-Chief of STEM CELLS Translational Medicine and director of the Wake Forest Institute for Regenerative Medicine. “The novel observation described in this study could potentially lead to a shift in the current paradigm of bone regenerative medicine.”

This study was conducted in collaboration with the Charles Perkins Centre and the Children’s Hospital at Westmead, University of Sydney.

The full article, “Reprogramming of human fibroblasts into osteoblasts by insulin-like growth factor binding protein 7,” can be accessed at https://stemcellsjournals.onlinelibrary.wiley.com/doi/abs/10.1002/sctm.19-0281.

About STEM CELLS Translational Medicine: STEM CELLS Translational Medicine (SCTM), co-published by AlphaMed Press and Wiley, is a monthly peer-reviewed publication dedicated to significantly advancing the clinical utilization of stem cell molecular and cellular biology. By bridging stem cell research and clinical trials, SCTM will help move applications of these critical investigations closer to accepted best practices. SCTM is the official journal partner of Regenerative Medicine Foundation.

About AlphaMed Press: Established in 1983, AlphaMed Press with offices in Durham, NC, San Francisco, CA, and Belfast, Northern Ireland, publishes two other internationally renowned peer-reviewed journals: STEM CELLS® (http://www.StemCells.com), celebrating its 38th year, is the world’s first journal devoted to this fast paced field of research. The Oncologist® (http://www.TheOncologist.com), also a monthly peer-reviewed publication, entering its 25th year, is devoted to community and hospital-based oncologists and physicians entrusted with cancer patient care. All three journals are premier periodicals with globally recognized editorial boards dedicated to advancing knowledge and education in their focused disciplines.

About Wiley: Wiley, a global company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical and scholarly journals, combined with our digital learning, assessment and certification solutions, help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 200 years, we have delivered consistent performance to our stakeholders. The company’s website can be accessed at http://www.wiley.com.

About Regenerative Medicine Foundation (RMF): The non-profit Regenerative Medicine Foundation fosters strategic collaborations to accelerate the development of regenerative medicine to improve health and deliver cures. RMF pursues its mission by producing its flagship World Stem Cell Summit, honouring leaders through the Stem Cell and Regenerative Medicine Action Awards, and promoting educational initiatives.

Business: Insurance

NFP Acquires Elective Benefit Services, Inc., Expanding its Group Benefits and Retirement Capabilities in Canada

Leave a comment


News Image

“NFP continues to invest in benefits offerings and demonstrate a commitment to delivering best-in-class solutions and services. This aligns perfectly with the values and philosophy we have put into practice for decades,” said McAdam.


NEW YORK (PRWEB)

NFP, a leading insurance broker and consultant that provides property and casualty (P&C), corporate benefits, retirement, and individual solutions, today announced the acquisition of Elective Benefit Services, Inc. (Elective Benefit) in a transaction that closed on June 12, 2019.

Elective Benefit, based in Waterloo, Ontario, specializes in group benefits and retirement planning. The firm has more than two decades of experience providing consultation, financial planning and administration support to their clients. Their expertise in group benefits and group retirement planning aligns well with NFP’s focus on expanding and diversifying its benefits business in Canada. Harold McAdam, president of Elective Benefit, has joined NFP in Canada as director, reporting to Dean Howard, managing director, benefits and retirement for NFP in Canada.

“Harold brings nearly 30 years of experience in the retirement and benefits space, managing specialized group plans for a range of organizations. We are thrilled to welcome Harold and his team of well-respected, high-performing producers to NFP,” said Greg Padovani, president of NFP in Canada.

“NFP continues to invest in benefits offerings and demonstrate a commitment to delivering best-in-class solutions and services. This aligns perfectly with the values and philosophy we have put into practice for decades,” said McAdam. “We’re excited to be part of NFP, contribute to NFP’s tremendous growth in Canada, and access resources that allow us to elevate the exceptional group retirement planning and consultative services our clients value.”

About NFP

NFP is a leading insurance broker and consultant providing specialized property and casualty, corporate benefits, retirement and individual solutions through its licensed subsidiaries and affiliates. NFP enables client success through the expertise of over 5,600 global employees, investments in innovative technologies, and enduring relationships with highly rated insurers, vendors, and financial institutions. NFP is the 5th largest benefits broker by global revenue, 6th largest US-based privately owned broker, and 8th best place to work in insurance (Business Insurance); 10th largest property and casualty agency (Insurance Journal); and 13th largest global insurance broker (Best’s Review).

Visit NFP.com to discover how NFP empowers clients to meet their goals.

Share article on social media or email:

Business: Executives

Geothermal Resources Council Announces New Board of Directors

Leave a comment


Join the global geothermal community!

“We congratulate the elected members of the Board on their success and welcome their talents and commitment.”


DAVIS, Calif. (PRWEB)

The global GRC membership took part in the ballot in November, and the result was that two new members of the Board were elected: Kelly Blake and Elisabeth de Jong.

They join two other members who have been re-elected to the Board of Directors: Ann Robertson Tait and Josh Nordquist.

The diverse membership of the Board of Directors reflects the mission of the GRC to represent the entire global geothermal community.

Will Pettitt, Executive Director of the GRC commented, “We congratulate the elected members of the Board on their success and welcome their talents and commitment. Our new board is 21 strong with 38% women. We continue to develop a diverse organization and strive for balanced gender representation. I look forward to working with the new Board on our transformative 2020 vision of increasing public awareness of geothermal energy across society.”

Photos of the new Board of Directors can be seen on the GRC Website at https://geothermal.org/bod.html

As of December 2019, the membership of the GRC stands at just under 1,200 with representation from nearly 40 different countries. If you would like to connect with this global geothermal community please consider joining the GRC and enjoy all the benefits of our association. As a GRC member you can also run for election to the Board of Directors and serve on Board committees. More information can be found at https://geothermal.org/membership.html

##

About the Geothermal Resources Council:

The Geothermal Resources Council (GRC) will be celebrating 50 years of service to the global geothermal energy community in 2022. The GRC is dedicated to advancing geothermal development around the world through education, research, and outreach. For more information, please visit http://www.geothermal.org.

Get your daily geothermal news at Global Geothermal News. Become a fan on Facebook. Join the geothermal community on LinkedIn. Follow GRC on Twitter [@GRC2001 and #GRCAM2020]. Check out GRC’s YouTube Channel. See geothermal photos on GRC’s Flicker page.

Share article on social media or email:



Health

Benzer Pharmacy Group and QualityCare Pharmacies Ink Deal

Leave a comment


Benzer Pharmacy Team, QualityCare Pharmacies & AshHEALTH LLC.

“We are thrilled that QualityCare Pharmacies has joined our GPO Model. Benzer offers a pharmacy support program aimed at transitioning population health across its member base into remuneration for every member affiliate.” Tonya Shackelford, Benzer Pharmacy, President


TAMPA, Fla. (PRWEB)

Tonya Shackelford, Benzer Pharmacy, President, “We are thrilled that QualityCare Pharmacies has joined our GPO Model. QualityCare members will benefit from the comprehensive healthcare program and preferred pricing and pharmacy management model driven through Benzer. Not to mention, Benzer offers a pharmacy support program aimed at transitioning population health across its member base into remuneration for every member affiliate.”

QualityCare Pharmacies has nearly 800 members that will now qualify to receive first rate prescription drug pricing and value-based care support services offered through Benzer Pharmacy Group Healthcare Hub of Programs.

“After an extensive search, we chose Benzer Pharmacy Group because of its commitment and proven track-record with its own stores to help our members grow their pharmacy business” states, Lanny Doud, Executive Director, QualityCare Pharmacies. Doud also adds, “It’s a difficult climate for independent pharmacy, we needed options for our members and Benzer offers that. They have built their pharmacy operations and support infrastructure around value-based care, this is a model our members need in order to increase patient traffic, win preferred employer and insurer contracts and enhance the value added patient services expected by our members.”

The companies acknowledged AshHEALTH LLC. founded by industry power broker, Ashton Maaraba for facilitating the transaction and for its outstanding leadership throughout the process.

About Benzer Pharmacy Group

Founded in 2009, Benzer Pharmacy is a chain of independent retail pharmacies specializing in compounding and specialty medication. Currently, there are 82 corporate-owned and 34 franchise locations situated throughout 29 states, including Florida, Michigan, Virginia, West Virginia, North

Carolina, Tennessee, Texas, Georgia, Nevada, Louisiana, New York, Missouri, Mississippi, Maryland, Ohio, Indiana, and Idaho. Projections call for continued rapid growth as the organization seeks to substantially increase its customer base, while ensuring experiences match expectations at every touchpoint.

Benzer Pharmacy has made four straight appearances on Inc. 5,000 list of the fastest growing private companies in America from 2015-2018; correspondingly, the company earned 39th place on the 2015 Florida Fast 100 list, while concurrently placing 67th on the 2015 TBBJ 200 list of Tampa Bay’s largest private companies. Benzer was also voted favorite pharmacy in the 2015 Best of Fuquay Varina in North Carolina, and achieved PCAB compounding accreditation with Accreditation Commission for Health Care (ACHC). All Benzer Pharmacy medications require a doctor’s prescription. To learn more about Benzer Pharmacy visit http://www.benzerpharmacy.com.

Facebook: https://www.facebook.com/BenzerPharmacy

LinkedIn: https://www.linkedin.com/company/benzerpharmacy

Instagram: https://instagram.com/benzer_pharmacy

SOURCE: Benzer Pharmacy

About QualityCare Pharmacies

QualityCare Pharmacies is a Buying Group servicing Independent Pharmacy in New York, New Jersey, Pennsylvania, Ohio, Connecticut, Vermont, New Hampshire, Maine, Massachusetts and Rhode Island. Through our partnerships we are able to offer an aggressive cost of goods along with significant rebate potential. We collect and return rebates based on compliant purchasing on branded Rx, generic compliance, plus many other vendor related categories.

Our current membership stands at 793 members and we have given back $92,633,619 in rebates since 1989. To learn more about QualityCare Pharmacies visit https://www.qcpharmacies.com/

About AshHEALTH LLC.

AshHEALTH LLC. aims to grow your Health & Wellness driven business, brand, product, service, identity and government affairs. AshHEALTH brokers opportunities for companies offering unique synergies, or those unable to gain market penetration, or faced with a struggling business in a competitive environment. To learn more about AshHEALTH LLC go to http://www.AshHEALTH.FIT

Share article on social media or email:



Legal / Law: Criminal Law

Reliefband® Wearable Devices for the Prevention and Treatment of Nausea Symptoms Receive FDA Approval for Expanded Uses

Leave a comment


“Millions in the U.S. suffer migraines and the most common associated symptoms are nausea and vomiting. These new indications mark an important step in our mission to mitigate the serious health issues and utter misery associated with nausea,” said Rich Ransom, President and CEO of Reliefband.


LAS VEGAS (PRWEB)

Reliefband Technologies LLC, an innovator in wearable technology that prevents and treats nausea and vomiting symptoms, announced its Reliefband® family of wearable therapeutic devices have received U.S. Food and Drug Administration (FDA) expanded indication clearance for nausea and vomiting associated with anxiety, hangovers and physician-diagnosed migraines.

The expanded use indications were approved for Reliefband products including the Classic and Premier models, as well as the new Reliefband Travel and Reliefband Sport models unveiled today at CES 2020. The expanded indications join Reliefband’s existing FDA-approved indications for symptoms associated with motion sickness, chemotherapy, morning sickness and nausea from postoperative surgery (as an adjunct to antiemetics).

Reliefband is an over-the-counter transdermal neuromodulation device that is applied to the underside of the wrist. Reliefband works by emitting gentle electrical pulses that stimulate the underlying median nerve. The signals generated on the underside of the wrist then flow to the central nervous system where they work, via the vagus nerve, to normalize stomach rhythms that cause nausea and prevent it.

“There are more than 38 million people in the U.S. who suffer migraines and the most common associated symptoms are nausea and vomiting. These newly-cleared indications mark an important step in our mission to mitigate the serious health issues and utter misery associated with nausea,” explained Rich Ransom, President and CEO of Reliefband Technologies, LLC. “We will continue to innovate our Reliefband technology, providing relief to those who suffer debilitating symptoms stemming from migraines, hangovers, anxiety and more.”

Reliefband will demonstrate the new Travel and Sport wearable devices and its entire family of products at CES 2020 from January 7-10 at the Sands Expo Convention Center, Tech West booth #46052 in the Wearables section and at CES Unveiled at Shorelines Exhibit Hall, Mandalay Bay on Sunday, January 5 from 5:00pm to 8:30pm at table #231.

For more information, please visit http://www.Reliefband.com.

About Reliefband® Technologies, LLC

Reliefband is a world leader in neuromodulation and wearable technology. The company’s patented, clinically proven wearable solution prevents and treats nausea and vomiting. Its unique, FDA-cleared neuromodulation technology was originally developed for use in hospitals and alters nerve activity through targeted delivery of gentle pulses to the underside of the wrist to “turn off” feelings of nausea and vomiting. Reliefband is a drug-free alternative that eliminates the discomfort associated with nausea and vomiting. The Reliefband wearable solution has been an industry leader for more than 20 years and is available OTC, at Reliefband.com and Amazon.com. For more information, visit http://www.Reliefband.com.

Share article on social media or email: